SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-024226
Filing Date
2022-05-05
Accepted
2022-05-05 16:01:45
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_inmunebioinc.htm   iXBRL 10-Q 458832
2 CERTIFICATION f10q0322ex31-1_inmunebio.htm EX-31.1 10787
3 CERTIFICATION f10q0322ex31-2_inmunebio.htm EX-31.2 10553
4 CERTIFICATION f10q0322ex32-1_inmunebio.htm EX-32.1 4389
5 CERTIFICATION f10q0322ex32-2_inmunebio.htm EX-32.2 4338
  Complete submission text file 0001213900-22-024226.txt   3347970

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20220331.xsd EX-101.SCH 49458
7 XBRL CALCULATION FILE inmb-20220331_cal.xml EX-101.CAL 24579
8 XBRL DEFINITION FILE inmb-20220331_def.xml EX-101.DEF 189443
9 XBRL LABEL FILE inmb-20220331_lab.xml EX-101.LAB 397213
10 XBRL PRESENTATION FILE inmb-20220331_pre.xml EX-101.PRE 199692
53 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_inmunebioinc_htm.xml XML 284037
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 22896035
SIC: 2836 Biological Products, (No Diagnostic Substances)